Iovance Biotherapeutics, Inc. Common Stock IOVA
$6.98
+7.06%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | OWNERSHIP DOCUMENT | 2026-08-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-08-10 | View → |
| 8-K | FORM 8-K | 2026-08-06 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | FORM 8-K | 2026-08-06 | View → |
| 8-K | FORM 8-K | 2026-07-02 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-18 | View → |
| 8-K | FORM 8-K | 2026-06-10 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-09 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-09 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-09 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-09 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-03 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-03 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-03 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-03 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-13 | View → |
| 8-K | FORM 8-K | 2026-05-07 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| DEF 14A | DEF 14A | 2026-04-28 | View → |
| 8-K | FORM 8-K | 2026-03-20 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-11 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-11 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-11 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-11 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-11 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-11 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-04 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-04 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-04 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-04 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-26 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $6.98
- Market Cap
- $3.05 billion
- 52-Week Range
- $1.70 – $7.00
- Average Volume
- 17.99 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.